In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Roche CEO Severin Schwan: Fueled By Innovation, Emerging Markets

Executive Summary

Roche’s CEO Severin Schwan says the Swiss group’s recent revamps, lack of patent expiries, and ongoing drug innovations give the world’s largest maker of cancer drugs a strong position to expand its sales globally, helped by new cutting-edge therapies and creative business approaches.


Related Content

Real World Data Solutions For Pharma’s Looming EBIT Crisis
Roche Follow-On Development Strategy Highlighted By Strong 1H Results
Isis Teams Up With Roche In Early-Stage Huntington’s Deal
Many New Oncology Drugs In 2012, With Prices That Test The Limits
Roche Shakes Up R&D, Closes Nutley Operations
Roche Wins Genentech After Months-Long Battle
Roche Diagnostics CEO Is No Ugly Duckling: Schwan Picked To Head Parent Corp.


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts